Literature DB >> 24107991

Multiple sclerosis: An old drug plays a new trick.

Hartmut Wekerle, Edgar Meinl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24107991     DOI： 10.1038/nature12694

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  13 in total

Review 1.  Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research.

Authors:  Ralf Gold; Christopher Linington; Hans Lassmann
Journal:  Brain       Date:  2006-04-21       Impact factor: 13.501

Review 2.  A brief history of the use of interferons as treatment of multiple sclerosis.

Authors:  L Jacobs; K P Johnson
Journal:  Arch Neurol       Date:  1994-12

3.  Chronic demyelination inhibits remyelination in the central nervous system. An analysis of contributing factors.

Authors:  S K Ludwin
Journal:  Lab Invest       Date:  1980-10       Impact factor: 5.662

4.  Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis.

Authors:  Ansi Chang; Wallace W Tourtellotte; Richard Rudick; Bruce D Trapp
Journal:  N Engl J Med       Date:  2002-01-17       Impact factor: 91.245

Review 5.  Multiple sclerosis: Prospects and promise.

Authors:  Stephen L Hauser; Jonah R Chan; Jorge R Oksenberg
Journal:  Ann Neurol       Date:  2013-09       Impact factor: 10.422

Review 6.  Bladder symptoms in multiple sclerosis: a review of pathophysiology and management.

Authors:  Richard Nicholas; Carolyn Young; Tim Friede
Journal:  Expert Opin Drug Saf       Date:  2010-11       Impact factor: 4.250

7.  Remyelination is extensive in a subset of multiple sclerosis patients.

Authors:  Peter Patrikios; Christine Stadelmann; Alexandra Kutzelnigg; Helmut Rauschka; Manfred Schmidbauer; Henning Laursen; Per Soelberg Sorensen; Wolfgang Brück; Claudia Lucchinetti; Hans Lassmann
Journal:  Brain       Date:  2006-08-18       Impact factor: 13.501

Review 8.  Neuroprotection in multiple sclerosis: a therapeutic challenge for the next decade.

Authors:  Anneke Van der Walt; Helmut Butzkueven; Scott Kolbe; Mark Marriott; Estella Alexandrou; Melissa Gresle; Gary Egan; Trevor Kilpatrick
Journal:  Pharmacol Ther       Date:  2010-02-01       Impact factor: 12.310

9.  A regenerative approach to the treatment of multiple sclerosis.

Authors:  Brian R Lawson; Peter G Schultz; Luke L Lairson; Vishal A Deshmukh; Virginie Tardif; Costas A Lyssiotis; Chelsea C Green; Bilal Kerman; Hyung Joon Kim; Krishnan Padmanabhan; Jonathan G Swoboda; Insha Ahmad; Toru Kondo; Fred H Gage; Argyrios N Theofilopoulos
Journal:  Nature       Date:  2013-10-09       Impact factor: 49.962

Review 10.  Remyelination in the CNS: from biology to therapy.

Authors:  Robin J M Franklin; Charles Ffrench-Constant
Journal:  Nat Rev Neurosci       Date:  2008-11       Impact factor: 34.870
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.